Boltzmann Labs
AI-Powered Drug Discovery Platform
Ready to see Boltzmann Labs in action?
Book a personalized demo with our team.
Overview
Boltzmann Labs offers a suite of AI-enabled tools for end-to-end drug discovery workflows, from small molecule design and synthesis planning to protein engineering and clinical outcome modeling. The platform leverages predictive algorithms and data-driven models to reduce experimental iterations and speed up early-stage research. Serving biotech firms, pharma R&D groups, and academic labs, it aims to cut development timelines and improve candidate success rates. Boltzmann also integrates multi-omics analysis and retrosynthesis capabilities to provide deeper insights into biological targets.
Who It's For
Pharmaceutical companies, Biotech researchers, Medicinal chemists, Academic research labs, Biotech startups
Key Strengths
AI-driven predictive modelsEnd-to-end drug discovery supportMulti-omics and protein engineeringAutomation of chemical design workflows
Primary Use Cases
Small molecule design and optimization
Protein engineering and antibody design
Retrosynthesis and synthetic pathway planning
Multi-omics biological target analysis
Clinical outcome modeling and trial predictions
Technical Specifications
Supported AI Models
Proprietary AI
Deployment Methods
Cloud
Supported Languages
English
Company Information
Location
Bengaluru, India
Company Size
11-50 employees